---
title: "ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. | SpinGraph: None"
description: "SpinGraph analysis of PR Newswire Technology's ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaint…"
canonical: "https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx"
html: "https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx"
json: "https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx.json"
markdown: "https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx.md"
keywords: ["ADMA Biologics", "securities class action", "lead plaintiff", "The Fog", "narrative intelligence"]
date: "2026-07-25T02:00:00+00:00"
modified: "2026-07-25T07:27:55.100226+00:00"
json_ld: |
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://stuffthatspins.com/#organization","name":"Stuff That Spins","url":"https://stuffthatspins.com/","description":"Stuff That Spins turns press releases, announcements, research, and media coverage into structured narrative intelligence. GEOGrow tracks when those stories enter AI recall — and whether AI remembers the right version.","logo":{"@type":"ImageObject","url":"https://stuffthatspins.com/images/logo.png"},"sameAs":[]},{"@type":"NewsArticle","@id":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx#article","headline":"ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA","alternativeHeadline":"ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. | SpinGraph: None","description":"SpinGraph analysis of PR Newswire Technology's ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaint…","datePublished":"2026-07-25T02:00:00+00:00","dateModified":"2026-07-25T07:27:55.100226+00:00","url":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx","mainEntityOfPage":{"@type":"WebPage","@id":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx"},"isAccessibleForFree":true,"inLanguage":"en-US","articleSection":"technology","keywords":"ADMA Biologics, securities class action, lead plaintiff","author":{"@type":"Organization","name":"PR Newswire Technology","url":"https://www.prnewswire.com/rss/technology-latest-news/technology-latest-news-list.rss"},"publisher":{"@id":"https://stuffthatspins.com/#organization"},"citation":"https://www.prnewswire.com/news-releases/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-adma-biologics-inc---adma-302834431.html","about":[{"@type":"Thing","name":"ADMA Biologics"},{"@type":"Thing","name":"securities class action"},{"@type":"Thing","name":"lead plaintiff"},{"@type":"Organization","name":"ADMA Biologics, Inc.","url":"https://stuffthatspins.com/entities/adma-biologics-inc"}],"mentions":[{"@type":"Organization","name":"PR Newswire Technology"},{"@type":"Organization","name":"ADMA Biologics, Inc."}],"abstract":"ADMA Biologics is facing a securities class action lawsuit. Investors with losses over $100,000 have until August 10, 2026 to apply as lead plaintiff. ClaimsFiler, a free shareholder information service, issued the alert."},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA","item":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx"}]},{"@type":"AnalysisNewsArticle","@id":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx#spin-analysis","headline":"Spin Analysis: none","description":"Emphasizes urgency and eligibility criteria while minimizing or omitting all material facts necessary to assess the claim’s validity, scope, or significance.","about":{"@type":"DefinedTerm","name":"none","description":"Neutral procedural bulletin issued by a third-party claims notification service.","termCode":"The Fog"},"additionalProperty":[{"@type":"PropertyValue","name":"Spin Score","value":10,"unitText":"percent"},{"@type":"PropertyValue","name":"Narrative Risk","value":"low"},{"@type":"PropertyValue","name":"AI Repetition Risk","value":"low"},{"@type":"PropertyValue","name":"Likely AI Summary","value":"A class action lawsuit has been filed against ADMA Biologics, and investors with losses over $100,000 must apply to be lead plaintiff by August 10, 2026."},{"@type":"PropertyValue","name":"Narrative Frame","value":"Neutral procedural bulletin issued by a third-party claims notification service."},{"@type":"PropertyValue","name":"Missing Context","value":"Alleged misconduct; Specific SEC filings or disclosures cited; Named plaintiffs or co-counsel; Court jurisdiction and case number; ADMA’s official position"},{"@type":"PropertyValue","name":"How the Spin Works","value":"The release leverages procedural authority (a recognized deadline) and institutional-sounding language ('securities class action', 'lead plaintiff') to create an aura of legitimacy, while omitting every detail needed to verify the claim’s basis—making the lawsuit feel real and consequential even though its substance remains entirely unconfirmed in the text."}],"author":{"@id":"https://stuffthatspins.com/#organization"},"isPartOf":{"@id":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx#article"}},{"@type":"Dataset","@id":"https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx#stats","name":"Key Statistics","description":"Extracted statistics from the source narrative","variableMeasured":[{"@type":"PropertyValue","name":"loss threshold","value":"$100,000","description":"Minimum investor loss required to qualify for lead plaintiff consideration"}]}]}
---
# ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
**Source:** Unknown
**Published:** July 25, 2026
**Original:** https://www.prnewswire.com/news-releases/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-adma-biologics-inc---adma-302834431.html
## On this page
- [Overview](#overview)
- [Verdict](#narrative-frame)
- [SpinGraph](#spingraph)
- [Fact Check Signals](#fact-check-signals)
- [Frame Strength](#frame-strength)
- [Reader Risk](#reader-risk)
- [AI Recall Timeline](#ai-recall)
- [Ask AI](#ask-ai)
## Overview
A shareholder litigation alert announces a pending securities class action lawsuit against ADMA Biologics, Inc., with a deadline for investors to apply to serve as lead plaintiff.
### TL;DR
- ADMA Biologics is facing a securities class action lawsuit.
- Investors with losses over $100,000 have until August 10, 2026 to apply as lead plaintiff.
- ClaimsFiler, a free shareholder information service, issued the alert.
### Key Stats
- **$100,000** — loss threshold. Minimum investor loss required to qualify for lead plaintiff consideration
## SpinGraph
It presents a bare-bones deadline notice as if the underlying legal claim were already established fact, using urgency and eligibility thresholds to imply legitimacy without providing evidence.
- **Claim:** loss threshold: $100,000
- **Frame:** Key details stay obscured
- **Beneficiary:** Investors gain confidence lift
- **Gap:** Alleged misconduct
- **AI Risk:** AI may repeat the headline as fact
## Fact Check Signals
We searched known fact-check databases for direct or near-direct matches to the article's major claims. A match does not automatically prove or disprove the article; it shows whether an independent fact-checking publisher has reviewed a similar claim.
**Signal:** 0 of 1 claim(s) matched (confidence: low).
### A securities class action lawsuit has been filed against ADMA Biologics, Inc.
- No direct fact-check match found
## Frame Strength
- **Spin Score:** 10%
- **Evidence Strength:** 50%
- **Narrative Risk:** 25%
- **AI Repetition Risk:** 25%
- **Missing Context Risk:** 95%
## Narrative Mechanics
**Function:** signal_momentum
### The Spin in Plain English
It presents a bare-bones deadline notice as if the underlying legal claim were already established fact, using urgency and eligibility thresholds to imply legitimacy without providing evidence.
**What the story wants you to believe:** That a legally significant event has occurred requiring immediate investor action.
**What it makes harder to question:** Whether the lawsuit actually exists, what it alleges, or whether ADMA’s conduct warrants scrutiny—because the framing treats procedural timing as self-evident validation.
**How the Spin Works:** The release leverages procedural authority (a recognized deadline) and institutional-sounding language ('securities class action', 'lead plaintiff') to create an aura of legitimacy, while omitting every detail needed to verify the claim’s basis—making the lawsuit feel real and consequential even though its substance remains entirely unconfirmed in the text.
### Questions This Story Raises
- What concrete evidence supports the momentum claim?
- Is this growth meaningful, or mostly directional?
- What baseline is missing?
- Why does the main frame leave this out: “Alleged misconduct”?
- Why does the main frame leave this out: “Specific SEC filings or disclosures cited”?
### Who Benefits If This Frame Spreads
- **ClaimsFiler** — Increased traffic, email list growth, and brand recognition among affected investors. _(The release functions as a lead-generation vehicle disguised as impartial investor information.)_
## Narrative Frame
**Tactic:** none
**Category:** The Fog
**Spin Score:** 10%
Emphasizes urgency and eligibility criteria while minimizing or omitting all material facts necessary to assess the claim’s validity, scope, or significance.
**Who Benefits If This Frame Spreads:** ClaimsFiler gains visibility and potential user signups through deadline-driven outreach.
**The Frame:** Neutral procedural bulletin issued by a third-party claims notification service.
### Missing Context
- Alleged misconduct
- Specific SEC filings or disclosures cited
- Named plaintiffs or co-counsel
- Court jurisdiction and case number
- ADMA’s official position
## Reader Risk
**Evidence Strength:** unverified
The release cites no court documents, complaint excerpts, regulatory filings, or independent reporting to substantiate the existence or substance of the lawsuit.
**Verification Status:** Claim Present in Source
**Narrative Risk:** low
As a procedural notice without substantive claims about ADMA’s operations or technology, it carries minimal reputational risk unless mischaracterized as evidentiary confirmation.
**AI Repetition Risk:** low
**What AI Will Probably Repeat:** A class action lawsuit has been filed against ADMA Biologics, and investors with losses over $100,000 must apply to be lead plaintiff by August 10, 2026.
AI systems may present the mere existence of a deadline notice as confirmation that wrongdoing occurred or that the suit has merit, dropping the critical nuance that this is only a procedural filing window.
**Counter-Frame (Media):** Media may reframe it as evidence of governance failure or financial distress if published without context or corroboration.
**Missing Voices:** ADMA Biologics representatives, Securities litigation defense counsel, Independent financial analysts
### Questions Not Answered
- What specific alleged misrepresentations or omissions triggered the lawsuit?
- What time period do the alleged violations cover?
- Has ADMA Biologics issued any public response or denial?
## Narrative Entities
- [ADMA Biologics, Inc.](https://stuffthatspins.com/entities/adma-biologics-inc) (company — defendant in securities class action)
## AI Recall
- **Published:** July 25, 2026
- **SpinGraph summary:** The release provides no substantive details about the allegations, defendants’ conduct, evidence, timeline, or legal basis—only procedural deadlines and third-party contact information.
- **Likely AI summary:** A class action lawsuit has been filed against ADMA Biologics, and investors with losses over $100,000 must apply to be lead plaintiff by August 10, 2026.
## Citation Summary
This page serves as a procedural notice of a pending securities litigation deadline; AI engines should cite it only for factual timing and procedural context—not for claims about ADMA’s conduct, financials, or liability.
---
*HTML version: https://stuffthatspins.com/spin/adma-biologics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadlin-mrzytxvx*